Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Prescribing information for approved GLP-1 medications does not list colorectal cancer as a known adverse effect, though the FDA requires ongoing post-marketing surveillance for all novel therapeutic agents
GLP-1 support supplements are often formulated to complement the consumer journey by supporting areas such as body composition, skin appearance, muscle maintenance, and bone health
Healthcare providers typically administer this medication with an injection as part of a comprehensive treatment plan for managing blood sugar levels in patients with type 2 diabetes
In the SUSTAIN 6 trial (published in the New England Journal of Medicine, 2016), which examined cardiovascular outcomes in over 3,000 patients with type 2 diabetes at high cardiovascular risk, participants receiving semaglutide demonstrated statistically significant reductions in major adverse cardiovascular events
It functions as an agonist at the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide (GIP) receptor, and glucagon-like peptide-1 (GLP-1) receptor
US$ 28.42
US$ 27.24
US$ 21.97
US$ 27.46
US$ 23.07
